Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure
Alimentary Pharmacology & Therapeutics · 16.10.2026
DOI: 10.1111/apt.71059 ↗Kurz gefasst
Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 16.10.2026. Verfasst von Yakup Demir. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Memorial Diyarbakir Hospital, Diyarbakir, Turkiye. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Memorial Diyarbakir Hospital, Diyarbakir, Turkiye.
ORCID-Profile: Yakup Demir
Zitieren
APA
Demir, Y. (2026). Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71059
Vancouver
Demir Y. Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71059
BibTeX
@article{Demir2026,
author = {Demir, Yakup},
title = {Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.71059}
}
EUVIMED